Hugo Fry becomes head of Zentiva's office in Russia
This article was originally published in Scrip
Zentiva, part of Sanofi–Aventis, has appointed Hugo Fry head of its representative office in Moscow, Russia. He succeeded Grigory Chudakov. Most recently, Mr Fry was director of oncology, diabetes and cardio-hospital departments at Sanofi–Aventis's Russian subsidiary where he had also served as marketing director.